Genmab A (GMAB) Other financing activities (2020 - 2026)

Genmab A (GMAB) has reported Other financing activities for 6 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities fell 85.71% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $26.0 million (down 29.73% YoY), and the FY2025 full-year result was $23.0 million, up 21.05% from the prior year.
• Other financing activities declined to $1.0 million in Q2 2026 per GMAB's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $32.0 million in Q1 2023 and bottomed at -$122.0 million in Q4 2023.
• Historically, Other financing activities has averaged -$2.5 million across 4 years, with a median of $8.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Other financing activities plunged 88.89% in 2025, then soared 100.0% in 2026.
• Over 4 years, Other financing activities stood at -$122.0 million in 2023, then jumped by 114.75% to $18.0 million in 2024, then slipped by 11.11% to $16.0 million in 2025, then slumped by 93.75% to $1.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $1.0 million, $2.0 million, and $16.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.